Mesa Laboratories, Inc.
MLAB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $644 | $603 | $930 | $1,328 |
| - Cash | $27 | $28 | $33 | $49 |
| + Debt | $181 | $231 | $170 | $221 |
| Enterprise Value | $798 | $806 | $1,067 | $1,500 |
| Revenue | $241 | $216 | $219 | $184 |
| % Growth | 11.5% | -1.3% | 18.8% | – |
| Gross Profit | $151 | $133 | $134 | $109 |
| % Margin | 62.6% | 61.6% | 61% | 59.2% |
| EBITDA | $42 | -$238 | $38 | $33 |
| % Margin | 17.6% | -110.3% | 17.1% | 17.6% |
| Net Income | -$2 | -$254 | $1 | $2 |
| % Margin | -0.8% | -117.6% | 0.4% | 1% |
| EPS Diluted | -0.36 | -47.2 | 0.17 | 0.35 |
| % Growth | 99.2% | -27,864.7% | -51.4% | – |
| Operating Cash Flow | $47 | $44 | $28 | $39 |
| Capital Expenditures | -$4 | -$3 | -$5 | -$4 |
| Free Cash Flow | $42 | $42 | $23 | $35 |